Literature DB >> 32180732

Corrigendum: An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection.

Chuantao Ye1,2, Dan Wang3, He Liu1, Hongwei Ma1, Yangchao Dong1, Min Yao1, Yuan Wang1, Hui Zhang1, Liang Zhang1, Linfeng Cheng1, Zhikai Xu1, Yingfeng Lei1, Fanglin Zhang1, Wei Ye1.   

Abstract

[This corrects the article DOI: 10.3389/fphar.2019.01203.].
Copyright © 2020 Ye, Wang, Liu, Ma, Dong, Yao, Wang, Zhang, Zhang, Cheng, Xu, Lei, Zhang and Ye.

Entities:  

Keywords:  BXA; FFA; T-705; hantavirus; viral nucleic acid synthesis inhibitors

Year:  2020        PMID： 32180732      PMCID： PMC7057847          DOI： 10.3389/fphar.2020.00201

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN： 1663-9812            Impact factor:   5.810


An author's name was incorrectly spelled as “Chuangtao Ye”. The correct spelling is “Chuantao Ye”. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
  1 in total

1.  Remdesivir (GS-5734) Impedes Enterovirus Replication Through Viral RNA Synthesis Inhibition.

Authors:  Wei Ye; Min Yao; Yangchao Dong; Chuantao Ye; Dan Wang; He Liu; Hongwei Ma; Hui Zhang; Libin Qi; Yuewu Yang; Yuan Wang; Liang Zhang; Linfeng Cheng; Xin Lv; Zhikai Xu; Yingfeng Lei; Fanglin Zhang
Journal:  Front Microbiol       Date:  2020-06-12       Impact factor: 5.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.